Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Step-Ups in DNA Chip IPOs

This article was originally published in Start Up

Executive Summary

Companies focused on DNA chips have been perennial favorites of the IPO market, from Affymetrix Inc.'s $90 million IPO in April 1996 to Nanogen Inc.'s $64 million offering, Affymetrix, Hyseq Inc., Vysis Inc. and Nanogen Inc. all received pre-money valuations about 3-4 times the total amount paid in by private investors prior to IPO, and post-money multiples of about 4.5 to 5.5.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts